» Articles » PMID: 25477247

Hepatitis C Virus-induced Reduction in MiR-181a Impairs CD4(+) T-cell Responses Through Overexpression of DUSP6

Overview
Journal Hepatology
Specialty Gastroenterology
Date 2014 Dec 6
PMID 25477247
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: T cells play a crucial role in viral clearance or persistence; however, the precise mechanisms that control their responses during viral infection remain incompletely understood. MicroRNA (miR) has been implicated as a key regulator controlling diverse biological processes through posttranscriptional repression. Here, we demonstrate that hepatitis C virus (HCV)-mediated decline of miR-181a expression impairs CD4(+) T-cell responses through overexpression of dual specific phosphatase 6 (DUSP6). Specifically, a significant decline of miR-181a expression along with overexpression of DUSP6 was observed in CD4(+) T cells from chronically HCV-infected individuals compared to healthy subjects, and the levels of miR-181a loss were found to be negatively associated with the levels of DUSP6 overexpression in these cells. Importantly, reconstitution of miR-181a or blockade of DUSP6 expression in CD4(+) T cells led to improved T-cell responses including enhanced CD25 and CD69 expression, increased interleukin-2 expression, and improved proliferation of CD4(+) T cells derived from chronically HCV-infected individuals.

Conclusion: Since a decline of miR-181a concomitant with DUSP6 overexpression is the signature marker for age-associated T-cell senescence, these findings provide novel mechanistic insights into HCV-mediated premature T-cell aging through miR-181a-regulated DUSP6 signaling and reveal new targets for therapeutic rejuvenation of impaired T-cell responses during chronic viral infection.

Citing Articles

ATM in immunobiology: From lymphocyte development to cancer immunotherapy.

Lee J Transl Oncol. 2025; 52():102268.

PMID: 39752906 PMC: 11754496. DOI: 10.1016/j.tranon.2024.102268.


The Role of Epigenetic Mechanisms in the Pathogenesis of Hepatitis C Infection.

Zychowska J, Cmil M, Skorka P, Olejnik-Wojciechowska J, Plewa P, Bakinowska E Biomolecules. 2024; 14(8).

PMID: 39199374 PMC: 11352264. DOI: 10.3390/biom14080986.


MicroRNAs in infectious diseases: potential diagnostic biomarkers and therapeutic targets.

Kimura M, Kothari S, Gohir W, Camargo J, Husain S Clin Microbiol Rev. 2023; 36(4):e0001523.

PMID: 37909789 PMC: 10732047. DOI: 10.1128/cmr.00015-23.


Analysis of self-renewing and differentiation-related microRNAs and transcription factors in multilineage mouse hematopoietic stem/progenitor cells induced by 1,4-benzoquinone.

Dewi R, Yusoff N, Razak S, Abd Hamid Z PeerJ. 2023; 11:e15608.

PMID: 37456886 PMC: 10340113. DOI: 10.7717/peerj.15608.


A DUSP6 inhibitor suppresses inflammatory cardiac remodeling and improves heart function after myocardial infarction.

Zhang Z, Chen Y, Zheng L, Du J, Wei S, Zhu X Dis Model Mech. 2022; 16(5).

PMID: 36478044 PMC: 9789401. DOI: 10.1242/dmm.049662.


References
1.
Yao Z, Moorman J . Immune exhaustion and immune senescence: two distinct pathways for HBV vaccine failure during HCV and/or HIV infection. Arch Immunol Ther Exp (Warsz). 2013; 61(3):193-201. PMC: 3792483. DOI: 10.1007/s00005-013-0219-0. View

2.
Wang J, Ma C, Li G, Wu X, Thayer P, Greer P . Tim-3 alters the balance of IL-12/IL-23 and drives TH17 cells: role in hepatitis B vaccine failure during hepatitis C infection. Vaccine. 2013; 31(18):2238-45. PMC: 3667544. DOI: 10.1016/j.vaccine.2013.03.003. View

3.
Rosen H . Emerging concepts in immunity to hepatitis C virus infection. J Clin Invest. 2013; 123(10):4121-30. PMC: 3784533. DOI: 10.1172/JCI67714. View

4.
Au J, Pockros P . Novel therapeutic approaches for hepatitis C. Clin Pharmacol Ther. 2013; 95(1):78-88. DOI: 10.1038/clpt.2013.206. View

5.
Shi L, Wang J, Ren J, Cheng Y, Ying R, Wu X . KLRG1 impairs CD4+ T cell responses via p16ink4a and p27kip1 pathways: role in hepatitis B vaccine failure in individuals with hepatitis C virus infection. J Immunol. 2013; 192(2):649-57. PMC: 3894750. DOI: 10.4049/jimmunol.1302069. View